Search
Displaying 151–160 of 790 for “retinitis clinical trial”
-
Sumitomo Pharma Receives FDA Orphan Drug Designation for Retinitis Pigmentosa Treatment
Research NewsPotential cell therapy, DSP-3077, gains special regulatory status to support development for inherited retinal disease.
-
Research News
Survey results will inform therapy developers and the agenda for a Patient-Focused Drug Development meeting with Food and Drug Administration representatives.
-
Bionic Sight’s Optogenetic Therapy Enables Blind Patients to Detect Light and Motion in Early Trial
Research NewsThe approach holds potential for restoring vision to people with little or no vision
-
Eye on the Cure
The Eye on the Cure Podcast from the Foundation Fighting Blindness provides science information, news, and insights from the world of vision and retinal diseases. The podcasts include conversations with guests from the research and vision communities. You can reach out to the host at podcast@fightingblindness.org.
-
Summary of the Ninth Annual Retinal Cell & Gene Therapy Innovation Summit 2024
Foundation NewsIn its ninth year, the Innovation Summit featured more than 30 presentations from retina experts from around the world with nearly 420 people in attendance.
-
Recording Available: Insights Forum | Thursday, March 26, 2026
Foundation NewsThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on March 26, 2026.
-
Recording Available: Insights Forum | Wednesday, August 27, 2025
Foundation NewsThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on August 27, 2025.
-
Recording Available: Insights Forum | Thursday, September 24, 2026
Foundation NewsThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on September 24, 2026.
-
Presentation Summaries from the 10th Annual Retinal Therapy Innovation Summit
Research NewsIn its tenth year, the Innovation Summit featured 28 presentations from industry professionals worldwide and more than 400 attendees.
-
Summary of the 11th Annual Retinal Therapeutics Innovation Summit
Research NewsThe 11th annual Retinal Therapeutics Innovation Summit featured 25 presentations from industry professionals worldwide and more than 400 attendees.
